格皮隆——市场上最新的抗抑郁药，是最新技术还是普通货色？

Gepirone-the latest antidepressant on market state-of-the-art or run-of-the-mill?

机构信息

Psychiatrist, Kuwait Centre for Mental Health (KCMH), State of Kuwait.

出版信息

Asian J Psychiatr. 2024 Apr;94:103937. doi: 10.1016/j.ajp.2024.103937. Epub 2024 Feb 3.

DOI:10.1016/j.ajp.2024.103937

Abstract

Gepirone was recently launched and FDA-approved for MDD. It belongs to azapirones group of psychotropics that is in popular use in Japan and China. Here, author wraps up current knowledge on gepirone contrasted with the older and cheaper anxiolytic buspirone.

摘要

Gepirone 最近被 FDA 批准用于治疗 MDD，并已上市。它属于苯二氮䓬类精神药物，在日本和中国广泛使用。在这里，作者总结了 gepirone 的现有知识，并与更老、更便宜的抗焦虑药丁螺环酮进行了对比。